AC Immune SA - ACIU Company Short-Term Debt

AC Immune Inc (ACIU) - corporate logo

AC Immune (ACIU) relies on collaborations with industry leaders to share research and development costs, which minimizes the burden on capital, although it delays the maximum financial impact. The confirmed price history on this chart shows that short-term debt stands at 0.00. This Swiss firm develops innovative drugs against brain degeneration, possessing unique technologies for profitable interaction with global corporations.

ACIU (acimmune.com) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Summary analytical data breakdowns for AC Immune Inc (ACIU)

- price and consensus price forecast:
Price Chart AC Immune SA|ACIU - Fair Value Consensus
- market capitalization data:
Market Value AC Immune SA|ACIU - Total Enterprise Value
- book capitalization data:
Book Value per Share AC Immune|ACIU - Book Capitalization|Market Capitalization to Book Value Ratio acimmune.com|ACIU - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio AC Immune|ACIU - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital AC Immune|ACIU - Company Total Debt Obligations|Debt to Book Capitalization Ratio AC Immune SA|ACIU - Company Long-Term Liabilities|Company Short-Term Debt AC Immune
Fundamental company valuation:AC Immune SA - ACIU
Signature product of AC Immune Inc

Investors are assessing the financial stability of AC Immune (ACIU) through the lens of liquidity management. This metric aggregates all liabilities with a maturity of up to one year, reflecting the current debt load. An analysis of the organization's short-term debt on GURU.Markets allows for tracking the speed of loan servicing. For a company utilizing outsourcing for production and clinical trials, this indicator is critically important when planning operational payments to contractors. Monitoring these debts confirms the effectiveness of the R&D financing strategy.

Competitor analysis for AC Immune

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|Axsome Corp (AXSM) - Short-Term Debt|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Short-Term Debts VKTX (Viking Therapeutics, Inc.)|Company Current Liabilities Supernus Pharmaceuticals, Inc. SUPN|Company Current Liabilities Catalyst Pharmaceuticals Inc|Company Short-Term Loans and Borrowings Denali Corp DNLI|Company Short-Term Debts HRMY (Harmony Biosciences)|BHVN: Short-Term Debt Volume|AMLX (Amylyx Pharmaceuticals, Inc.) - Company Short-Term Debt|TRVI (Trevi Therapeutics Inc) - Company Current Liabilities|Company Short-Term Debt PRAX|Company Current Liabilities Anavex Life Sciences Corp (AVXL)|Company Current Liabilities CBLL|Company Short-Term Debts PRTA (Prothena Corporation plc)|ALEC - Company Short-Term Debt|Company Short-Term Indebtedness Annexon Biosciences ANNX|OMER (Omeros Corp.) - Company Short-Term Debts|NGNE - Short-Term Debt|VYGR: Company Short-Term Debts|neumoratx.com (NMRA) - Company Short-Term Debts|Company Short-Term Debts SCLX|Company Current Liabilities Tevogen Bio Holdings Inc.|ACOG (Alpha Cognition) - Company Short-Term Debts|Short-Term Debt Volume cogrx.com CGTX|Company Current Liabilities IKT (Inhibikase Therapeutics)|cassavasciences.com - Company Short-Term Debts|Assertio Therapeutics (ASRT) - Company Short-Term Debt|COYA - Company Short-Term Indebtedness|Company Short-Term Debts VTGN|Short-Term Debt Ovid Therapeutics|ABOS (Acumen Pharmaceuticals) - Company Current Liabilities|Company Short-Term Debts CRVO|Alterity Therapeutics (ATHE) - Company Short-Term Debt|Company Short-Term Loans and Borrowings CLNN (clene.com)|PEPG: Company Short-Term Debt|Short-Term Debt jupiterneurosciences.com JUNS|Relmada Therapeutics - Company Short-Term Debts|ANVS - Company Short-Term Debts|GRCE (gracetx.com) - Company Short-Term Debts|Company Current Liabilities Firefly Neuroscience, Inc.|KLTO - Company Current Liabilities|Company Short-Term Loans and Borrowings NeuroSense Therapeutics, Ltd.|RVPH (Reviva Pharmaceuticals) - Company Short-Term Debts|Short-Term Debt Volume MTVA (metaviatx.com)|NeurAxis - Company Short-Term Debt|Helius Medical Technologies, Inc. - Company Current Liabilities|PASG: Company Short-Term Debt|Neuphoria Therapeutics Inc. (NEUP) - Company Current Liabilities|NERV: Company Current Liabilities|ATHA (athira.com) - Company Short-Term Debts|Company Short-Term Debt Addex Therapeutics Ltd (ADXN)|Company Short-Term Indebtedness Alzamend|Cyclerion Therapeutics - Company Short-Term Debts|Short-Term Debt protagenic.com (PTIX)|Company Short-Term Debts KTTA (Pasithea Therapeutics Corp.)|Company Short-Term Debts Cortigent Inc CRGT|ATXI: Company Short-Term Debts|BCLI - Company Current Liabilities|Cara Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt Volume Chromocell|ELYM (Eliem Therapeutics, Inc.) - Company Current Liabilities|Company Short-Term Debts ITCI|Company Short-Term Debt Longboard Pharmaceuticals, Inc. LBPH|Company Short-Term Indebtedness Marinus Pharmaceuticals Inc (MRNS)|NKGN: Company Short-Term Debts|NRBO - Short-Term Debt|Sage Therapeutics, Inc. - Company Current Liabilities|SNPX: Company Short-Term Debts|Company Short-Term Debt Trevena TRVN|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt WENA (Anew Medical, Inc.)|Short-Term Debt Cerevel Corp